Open AccessNEORAL COMPARED TO SANDIMMUNE IS ASSOCIATED WITH A DECREASE IN HISTOLOGIC SEVERITY OF REJECTION IN PATIENTS UNDERGOING PRIMARY LIVER TRANSPLANTATION1
Author(s) -
Ivo Graziadei,
Russell H. Wiesner,
Paul Marotta,
Michael K. Porayko,
Linda J. Dahlke,
Sharon Wilson,
Jeffery L. Steers,
Ruud A.F. Krom
Publication year - 1997
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199709150-00011
Subject(s) - medicine , discontinuation , etiology , gastroenterology , surgery , transplantation , liver transplantation , cyclosporins , immunosuppressive drug , ciclosporin
In a randomized, controlled study we investigated the clinical efficacy of the microemulsion formulation of cyclosporine (Neoral) in comparison with Sandimmune (SIM) in the treatment of patients who underwent primary orthotopic liver transplantation (OLT).